Clinical Trials in Seattle

Showing 6101-6120 of 9,312 trials

Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

NCT01729845

This phase I/II trial studies the side effects and best dose of decitabine followed by mitoxantrone hydrochloride, etoposide, and cytarabine and to see how well they work in treating patients with acute myeloid leukemia or high-risk myelodysplastic syndrome that has returned after a period of improvement or does not respond to treatment. Drugs used in chemotherapy, such as mitoxantrone hydrochloride, etoposide, cytarabine, and decitabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug (combination chemotherapy) may kill more cancer cells.

Previously Treated Myelodysplastic SyndromeRecurrent Adult Acute Myeloid Leukemia

Fred Hutchinson Cancer Center52 participantsStarted Dec 2012

Kennewick, Washington, United States • Kirkland, Washington, United States • Seattle, Washington, United States

TERMINATEDPhase 3< 1 mile

ESCAPE Migraine Trial

NCT00267371

The purpose of this two arm controlled double-blind study is to determine the safety and effectiveness of PFO closure (closing a hole in the wall of the heart) in reducing the frequency of migraine headaches, in patients who experience migraine headaches and have a PFO, compared to medical therapy alone.

Migraine DisordersHeart Septal Defects, Atrial

Abbott Medical Devices168 participantsStarted Nov 2005

Scottsdale, Arizona, United States • Newport Beach, California, United States • Sacramento, California, United States +34 more locations

Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

ESCAPE Migraine Trial

Find Trials by Condition in Seattle

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study

Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)

A Prospective Clinical Outcomes Registry

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene

CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements

Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors

Dissemination of the Lupus Interactive Navigator

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase

SUNBURST (Success Using Neuromodulation With BURST) Study

A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia

Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree